Novadip recruits first pediatric patients in pivotal phase 3 trial of tissue regenerative treatment
Phase 3 trial in adult patients also planned for 2026 with focus on limb sparing associated with bone non-union (BNU) Novadip Biosciences, a late-stage clinical biotechnolo...